Interestingly, 2D and 3D cell studies revealed their ability to induce human cancer cell death in the low micromolar range, being extremely effective against KRAS mutated cancer cells with a better cytotoxicity profile than that shown by DCA and resembling that of the reference clinically approved drug gemcitabine. The gene discussed is KRAS; the disease is cancer.